Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
VTP-500 by Barinthus Biotherapeutics for Middle East Respiratory Syndrome (MERS): Likelihood of Approval
VTP-500 is under clinical development by Barinthus Biotherapeutics and currently in Phase I for Middle East Respiratory Syndrome (MERS). According...